Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
Open Access
- 8 September 2016
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 32958
Abstract
Mature thrombin activatable fibrinolysis inhibitor (TAFIa) is a carboxypeptidase that stabilizes fibrin clots by removing C-terminal arginines and lysines from partially degraded fibrin. Inhibition of TAFIa stimulates the degradation of fibrin clots and may help to prevent thrombosis. Applying a lead finding approach based on literature-mining, we discovered that anabaenopeptins, cyclic peptides produced by cyanobacteria, were potent inhibitors of TAFIa with IC50 values as low as 1.5 nM. We describe the isolation and structure elucidation of 20 anabaenopeptins, including 13 novel congeners, as well as their pronounced structure-activity relationships (SAR) with respect to inhibition of TAFIa. Crystal structures of the anabaenopeptins B, C and F bound to the surrogate protease carboxypeptidase B revealed the binding modes of these large (~850 Da) compounds in detail and explained the observed SAR, i.e. the strong dependence of the potency on a basic (Arg, Lys) exocyclic residue that addressed the S1’ binding pocket, and a broad tolerance towards substitutions in the pentacyclic ring that acted as a plug of the active site.Keywords
This publication has 36 references indexed in Scilit:
- Management of Antithrombotic Therapy in Patients Undergoing Invasive ProceduresNew England Journal of Medicine, 2013
- Thrombin Activatable Fibrinolysis Inhibitor: A Putative Target to Enhance FibrinolysisSeminars in Thrombosis and Hemostasis, 2013
- A genome-wide analysis of nonribosomal peptide synthetase gene clusters and their peptides in a Planktothrix rubescens strainBMC Genomics, 2009
- Homotyrosine-Containing Cyanopeptolins 880 and 960 and Anabaenopeptins 908 and 915 from Planktothrix agardhii CYA 126/8Journal of Natural Products, 2008
- The Crystal Structure of Thrombin-activable Fibrinolysis Inhibitor (TAFI) Provides the Structural Basis for Its Intrinsic Activity and the Short Half-life of TAFIaJournal of Biological Chemistry, 2008
- Chemogenomic approaches to drug discovery: similar receptors bind similar ligandsBritish Journal of Pharmacology, 2007
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Bleeding risks of antithrombotic therapyBMJ, 2002
- Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic PropertiesJournal of Biological Chemistry, 1998
- Oscillamide Y, A Chymotrypsin Inhibitor from Toxic Oscillatoria AgardhiiTetrahedron Letters, 1995